Search for: "AIPLA" Results 381 - 400 of 610
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Mar 2008, 3:54 am
The applicant would provide this correction to the claim by submitting an amendment to the application.To estimate the cost of amending an application in order to correct the format of the claim(s), the Office is using unit cost data on amendments from the AIPLA Report of the Economic Survey.3 Based on the AIPLA data, the Office estimates that the cost of filing one amendment to correct the format of the claim(s) is $4,029 (expressed in present value terms using a 7 percent… [read post]
27 Apr 2007, 12:04 pm
By Hal WegnerBefore an overflow hearing room on an internationally available web broadcast, Chairman Howard Berman of the House Judiciary Subcommittee relevant to patents hosted a most informative and candid hearing yesterday afternoon joined by roughly ten of his committee colleagues, including Rep. [read post]
16 Oct 2006, 9:44 pm
American Intellectual Property Law Association (AIPLA) in Support of Respondent: AIPLA’s brief is a fun read — it starts off with quotes from Billy Wilder and King Solomon, both of which give us pause on the question of hindsight. [read post]
9 Mar 2011, 8:31 pm by Marie Louise
A tireless campaigner for US patent reform, he has testified before Congress on IP policy issues and is a past president of the AIPLA. [read post]
14 Oct 2006, 10:05 am
AIPLA amicus brief supporting Figueroa at the Court of Federal Claims. [read post]
16 Jun 2008, 7:06 pm
" Rocket Docket Examination: In the past, the AIPLA and others have argued against having a rocket-docket examination based simply on the payment of a fee. [read post]
1 Feb 2010, 7:33 am by Lawrence B. Ebert
Todd Dickinson, the executive director of the American Intellectual Property Law Association [AIPLA] and a former director of the Patent Office. [read post]
31 May 2012, 10:00 pm by Stephanie Figueroa
This article considers what technology companies are fighting over, their reasons for fighting, the impact on consumers, and the bottom line of the patent wars. 5) PharmaPatents: Patent Reform Q & A – Courtenay Brinckerhoff, Foley & Lardner Partner and Practice Center contributor, posted on her blog the questions she received as a panelist at the AIPLA webinar, “Patent Prosecution Under The AIA. [read post]
16 Jul 2007, 8:23 pm
AIPLA’s amicus brief supports Bilski and a broad interpretation of patentable subject matter. [read post]
9 Feb 2011, 8:06 pm
For the record, the cast of speakers includes one of Europe's most prominent and outspoken patent judges, Lord Justice Jacob, the AIPLA's Q. [read post]
27 Mar 2008, 11:01 pm
It will, of course, be interesting to see whether the IPO and AIPLA have altered their positions in the past two years. [read post]
31 May 2012, 10:00 pm by Stephanie Figueroa
This article considers what technology companies are fighting over, their reasons for fighting, the impact on consumers, and the bottom line of the patent wars. 5) PharmaPatents: Patent Reform Q & A – Courtenay Brinckerhoff, Foley & Lardner Partner and Practice Center contributor, posted on her blog the questions she received as a panelist at the AIPLA webinar, “Patent Prosecution Under The AIA. [read post]
19 Dec 2007, 8:52 am
As to "who is where" on patent reform, the AIPLA and the IPO seem to be mostly in FAVOR of the proposed reforms. [read post]
24 Sep 2017, 5:04 pm by Dennis Crouch
In June, Helsinn filed for en banc review with support from the big players: Helsinn-Petition Teva-Response AIPLA (prior “on sale” activity must make the invention available to the public) BIO (negative consequences will flow from the panel decision) Boston (court should take the case and decide the issue) IPO (court should rule en banc, decision is contrary to MedCo) PhRMA (the legislative history “reflects [Congress’s]… [read post]
31 Oct 2015, 5:27 am by Dennis Crouch
 Thus, I expect that any IPO/AIPLA (and probably PTO) commentary on this front will support the current automatic-assignment rule. **** * I included the asterisk next to “moment” of invention because of the reality that invention is typically a process distributed over time. [read post]
31 Dec 2008, 6:04 am
  It is with great thanks that I note those that bring many of the visitors to our site: IP Newsflash Patently-O Orange Book Blog Patent Docs Pharmalot 271 Patent Blog Securing Innovation IP Think Tank AIPLA IP Outline Patent Circle Patent Hawk Genome Technology Online Likelihood of Confusion Above the Law Cafe Pharma Here’s wishing you and yours a great year in 2009! [read post]
11 Jul 2007, 11:07 am
It appears that neither the IPO or AIPLA are actively opposing the rule changes. [read post]
7 Aug 2010, 4:46 am by Dennis Crouch
Court Decisions: District Court Opinion Original Panel Decision En Banc Order Party Briefs: TheraSense (Abbott) Opening Brief: TheraSense.pdf (608 KB) Amicus Brief filed in Support of TheraSense Sanofi-Aventis and Microsoft: AventisMicrosoft.pdf (791 KB) Ole Nilssen: Nilssen.pdf (1608 KB) Amici Briefs filed in Support of Neither Party Apotex: Apotex.pdf (904 KB)  United States Patent & Trademark Office (USPTO): USPTO.pdf (770 KB) Intellectual Property Owners Association… [read post]